A new FDA approved drug offers hope to children with progeria
Science News - 25-Nov-2020Zokinvy blocks production of a defective protein to lengthen the shortened life span
Eiger BioPharmaceuticals
Biopharmaceutical company focused on the development and commercialisation of drugs for rare diseases
Eiger is a late-stage biopharmaceutical company focused on the development and commercialisation of first-in-class, well-characterised drugs for serious rare and ultra-rare diseases for patients with high unmet medical needs, for which no approved therapies.
Visit website: https://eigerbio.com
Details last updated 30-Nov-2020
Eiger BioPharmaceuticals News
